{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:28:09Z","timestamp":1790735289159,"version":"4.1.0"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["ACF-2022-26-003"],"award-info":[{"award-number":["ACF-2022-26-003"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Applied"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.nsa.2023.103922","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T06:09:11Z","timestamp":1699596551000},"page":"103922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The role of the orexin system in the neurobiology of anxiety disorders: Potential for a novel treatment target"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8573-3024","authenticated-orcid":false,"given":"Harry A.","family":"Fagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5981-6707","authenticated-orcid":false,"given":"Nathan T.M.","family":"Huneke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Domschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nsa.2023.103922_bib1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fnbeh.2015.00324","article-title":"Comprehensive behavioral analysis of male Ox1r (-\/-) mice showed implication of orexin receptor-1 in mood, anxiety, and social behavior","volume":"9","author":"Abbas","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.nsa.2023.103922_bib2","article-title":"Orexinergic modulation of serotonin neurons in the dorsal raphe of a diurnal rodent","volume":"116","author":"Adidharma","year":"2019","journal-title":"Arvicanthis Niloticus. Horm. Behav."},{"issue":"2","key":"10.1016\/j.nsa.2023.103922_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/13651501.2019.1711425","article-title":"Orexin A in adolescents with anxiety disorders","volume":"24","author":"Ak\u00e7a","year":"2020","journal-title":"Int. J. Psychiatr. Clin. Pract."},{"key":"10.1016\/j.nsa.2023.103922_bib4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11325-019-01890-8","article-title":"Comorbid psychiatric disorders among patients with narcolepsy","volume":"24","author":"Alasim H","year":"2020","journal-title":"Sleep Breath."},{"issue":"s2","key":"10.1016\/j.nsa.2023.103922_bib5","first-page":"3","article-title":"ESEMeD\/MHEDEA 2000 scientific committee, overview of key data from the European study of the epidemiology of mental disorders (ESEMeD)","volume":"68","author":"Alonso","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.nsa.2023.103922_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/da.22711","article-title":"Treatment gap for anxiety disorders is global: results of the World Mental Health Surveys in 21 countries","volume":"35","author":"Alonso","year":"2018","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.nsa.2023.103922_bib7","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"issue":"2","key":"10.1016\/j.nsa.2023.103922_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/YPG.0b013e328341a3db","article-title":"Panic disorder is associated with the Val308Iso polymorphism in the hypocretin receptor gene","volume":"21","author":"Annerbrink","year":"2011","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.nsa.2023.103922_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.psyneuen.2013.10.010","article-title":"Anxiolytic function of the orexin 2\/hypocretin A receptor in the basolateral amygdala","volume":"40","author":"Arendt","year":"2014","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.nsa.2023.103922_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12868-018-0445-9","article-title":"The effect of intracerebroventricular administration of orexin receptor type 2 antagonist on pentylenetetrazol-induced kindled seizures and anxiety in rats","volume":"19","author":"Asadi","year":"2018","journal-title":"BMC Neurosci."},{"issue":"2","key":"10.1016\/j.nsa.2023.103922_bib11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bbr.2010.11.014","article-title":"Amygdalar orexinergic-GABAergic interactions regulate anxiety behaviors of the Syrian golden hamster","volume":"218","author":"Avolio","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"12","key":"10.1016\/j.nsa.2023.103922_bib12","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/WNR.0000000000000213","article-title":"Distinct anxiogenic\/anxiolytic effects exerted by the hamster lateral amygdalar nucleus injected with ORX-A or ORX-B in the presence of a GABAergic agonist","volume":"25","author":"Avolio","year":"2014","journal-title":"Neuroreport"},{"key":"10.1016\/j.nsa.2023.103922_bib13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11920-020-01159-y","article-title":"Neuropsychiatric correlates of narcolepsy","volume":"22","author":"BaHammam","year":"2020","journal-title":"Curr. Psychiatr. Rep."},{"issue":"5","key":"10.1016\/j.nsa.2023.103922_bib14","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3390\/molecules25051018","article-title":"A new positron emission tomography probe for orexin receptors neuroimaging","volume":"25","author":"Bai","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.nsa.2023.103922_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.pbb.2008.04.002","article-title":"GABA-A receptors and the response to CO(2) inhalation - a translational trans-species model of anxiety?","volume":"90","author":"Bailey","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"9","key":"10.1016\/j.nsa.2023.103922_bib16","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1177\/0269881111408455","article-title":"Validating the inhalation of 7.5% CO(2) in healthy volunteers as a human experimental medicine: a model of generalized anxiety disorder (GAD)","volume":"25","author":"Bailey","year":"2011","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.nsa.2023.103922_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0269881114525674","article-title":"Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology","volume":"28","author":"Baldwin","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.nsa.2023.103922_bib18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.31887\/DCNS.2015.17.3\/bbandelow","article-title":"Epidemiology of anxiety disorders in the 21st century","volume":"17","author":"Bandelow","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.nsa.2023.103922_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/YIC.0000000000000078","article-title":"Efficacy of treatments for anxiety disorders: a meta-analysis","volume":"30","author":"Bandelow","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.nsa.2023.103922_bib20","first-page":"1","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - version 3. Part I: anxiety disorders","volume":"24","author":"Bandelow","year":"2022","journal-title":"World J. Biol. Psychiatr."},{"issue":"5","key":"10.1016\/j.nsa.2023.103922_bib21","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1017\/S003329171200147X","article-title":"Global prevalence of anxiety disorders: a systematic review and meta-regression","volume":"43","author":"Baxter","year":"2013","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.nsa.2023.103922_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12915-017-0463-6","article-title":"An elevated plus-maze in mixed reality for studying human anxiety-related behavior","volume":"15","author":"Biedermann","year":"2017","journal-title":"BMC Biol."},{"key":"10.1016\/j.nsa.2023.103922_bib23","unstructured":"Bioicons, 7helix-receptor-membrane\u201d image. https:\/\/bioicons.com\/Accessed 26 June 2023."},{"issue":"8","key":"10.1016\/j.nsa.2023.103922_bib24","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.neubiorev.2013.06.008","article-title":"The role of behavior in translational models for psychopathology: functionality and dysfunctional behaviors","volume":"37","author":"Blanchard","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nsa.2023.103922_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuroscience.2018.04.005","article-title":"Sex- and age-dependent effects of orexin 1 receptor blockade on open-field behavior and neuronal activity","volume":"381","author":"Blume","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.nsa.2023.103922_bib26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fphar.2017.00357","article-title":"Evaluation of JNJ-54717793 a novel brain penetrant selective orexin 1 receptor antagonist in two rat models of panic attack provocation","volume":"8","author":"Bonaventure","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.nsa.2023.103922_bib27","first-page":"663","article-title":"Estimating the prevalence of mental disorders in U.S. Adults from the epidemiologic catchment area survey","volume":"107","author":"Bourdon","year":"1992","journal-title":"Publ. Health Rep."},{"issue":"10","key":"10.1016\/j.nsa.2023.103922_bib28","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/nn.4101","article-title":"Resolving the neural circuits of anxiety","volume":"18","author":"Calhoon","year":"2015","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.nsa.2023.103922_bib29","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00429-013-0626-3","article-title":"Orexins (hypocretins) contribute to fear and avoidance in rats exposed to a single episode of footshocks","volume":"219","author":"Chen","year":"2014","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.nsa.2023.103922_bib30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jad.2019.12.010","article-title":"Sex and age differences in the association between anxiety disorders and narcolepsy: a nationwide population-based case control study","volume":"264","author":"Chen","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.nsa.2023.103922_bib31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.sleep.2017.11.1125","article-title":"Comorbidities in a community sample of narcolepsy","volume":"43","author":"Cohen A","year":"2018","journal-title":"Sleep Med."},{"key":"10.1016\/j.nsa.2023.103922_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.812359","article-title":"Orexin signaling: a complex, multifaceted process","volume":"16","author":"Dale","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nsa.2023.103922_bib33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1440-1681.2010.05413.x","article-title":"Role of the medial amygdala in mediating responses to aversive stimuli leading to hypertension","volume":"38","author":"Davern","year":"2011","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"7","key":"10.1016\/j.nsa.2023.103922_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112815","article-title":"Hypocretin\/orexin neurons encode social discrimination and exhibit a sex-dependent necessity for social interaction","volume":"42","author":"Dawson","year":"2023","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.nsa.2023.103922_bib35","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.nsa.2023.103922_bib36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fnbeh.2015.00161","article-title":"Blocking of orexin receptors in the paraventricular nucleus of the thalamus has no effect on the expression of conditioned fear in rats","volume":"9","author":"Dong","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.nsa.2023.103922_bib37","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3389\/fnins.2018.00934","article-title":"Orexin depolarizes central amygdala neurons via orexin receptor 1, phospholipase C and sodium-calcium exchanger and modulates conditioned fear","volume":"12","author":"Dustrude","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nsa.2023.103922_bib38","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.bbr.2018.05.032","article-title":"Orexin signaling during social defeat stress influences subsequent social interaction behaviour and recognition memory","volume":"356","author":"Eacret","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nsa.2023.103922_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.147199","article-title":"Orexin deficiency affects sociability and the acquisition, expression, and extinction of conditioned social fear","volume":"1751","author":"Faesel","year":"2021","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.nsa.2023.103922_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40263-022-00974-6","article-title":"Orexin receptor antagonists in the treatment of depression: a leading article summarising pre-clinical and clinical studies","volume":"37","author":"Fagan","year":"2023","journal-title":"CNS Drugs"},{"key":"10.1016\/j.nsa.2023.103922_bib41","series-title":"Investigating the Effect of Dual Orexin Receptor Antagonism in an Experimental Model of Anxiety in Healthy Volunteers: A Translational Study Protocol","author":"Fagan","year":"2023"},{"issue":"12","key":"10.1016\/j.nsa.2023.103922_bib42","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1038\/npp.2014.146","article-title":"The hypocretin\/orexin system mediates the extinction of fear memories","volume":"39","author":"Flores","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.nsa.2023.103922_bib43","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/bph.13440","article-title":"Involvement of the orexin\/hypocretin system in the pharmacological effects induced by \u0394(9) -tetrahydrocannabinol","volume":"173","author":"Flores","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.nsa.2023.103922_bib44","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/ijnp\/pyx029","article-title":"Facilitation of contextual fear extinction by orexin-1 receptor antagonism is associated with the activation of specific amygdala cell subpopulations","volume":"20","author":"Flores","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.nsa.2023.103922_bib45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.genhosppsych.2009.08.007","article-title":"Anxiety and mood disorders in narcolepsy: a case-control study","volume":"32","author":"Fortuyn","year":"2010","journal-title":"Gen. Hosp. Psychiatr."},{"key":"10.1016\/j.nsa.2023.103922_bib46","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.sleep.2011.01.013","article-title":"Narcolepsy and psychiatry: an evolving association of increasing interest","volume":"12","author":"Fortuyn","year":"2011","journal-title":"Sleep Med."},{"issue":"9","key":"10.1016\/j.nsa.2023.103922_bib47","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1210\/jc.2005-0296","article-title":"The number of hypothalamic hypocretin (orexin) neurons is not affected in prader-willi syndrome","volume":"90","author":"Fronczek","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.nsa.2023.103922_bib48","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hup.2436","article-title":"Arousal and the attentional network in panic disorder","volume":"29","author":"Geiger","year":"2014","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.nsa.2023.103922_bib49","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.conb.2014.07.006","article-title":"Hypocretin (orexin) neuromodulation of stress and reward pathways","volume":"29","author":"Giardino","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"issue":"8","key":"10.1016\/j.nsa.2023.103922_bib50","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41593-018-0198-x","article-title":"Parallel circuits from the bed nuclei of stria terminalis to the lateral hypothalamus drive opposing emotional states","volume":"21","author":"Giardino","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.nsa.2023.103922_bib51","first-page":"308","article-title":"Acute orexin antagonism selectively modulates anticipatory anxiety in humans: implications for addiction and anxiety, Transl","volume":"21","author":"Gorka","year":"2022","journal-title":"Psychiatry"},{"issue":"1","key":"10.1016\/j.nsa.2023.103922_bib52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41398-019-0415-8","article-title":"Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder\/agoraphobia, CBT treatment response and fear-related intermediate phenotypes","volume":"9","author":"Gottschalk","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nsa.2023.103922_bib53","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0273-17.2018","article-title":"Reduced orexin system function contributes to resilience to repeated social stress","volume":"5","author":"Grafe","year":"2018","journal-title":"eNeuro"},{"issue":"9","key":"10.1016\/j.nsa.2023.103922_bib54","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrd4075","article-title":"50 years of hurdles and hope in anxiolytic drug discovery","volume":"12","author":"Griebel","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.nsa.2023.103922_bib55","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/s41386-019-0445-1","article-title":"Modeling anxiety in healthy humans: a key intermediate bridge between basic and clinical sciences","volume":"44","author":"Grillon","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.nsa.2023.103922_bib56","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.neubiorev.2012.09.001","article-title":"Classical and novel approaches to the preclinical testing of anxiolytics: a critical evaluation","volume":"37","author":"Haller","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nsa.2023.103922_bib57","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.physbeh.2013.10.005","article-title":"Optogenetic examination identifies a context-specific role for orexins\/hypocretins in anxiety-related behavior","volume":"130","author":"Heydendael","year":"2014","journal-title":"Physiol. Behav."},{"issue":"5","key":"10.1016\/j.nsa.2023.103922_bib58","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41583-020-0292-4","article-title":"Circuits and functions of the lateral habenula in health and in disease","volume":"21","author":"Hu","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nsa.2023.103922_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114770","article-title":"A novel procedure to investigate social anxiety using videoconferencing software: a proof-of-concept study","volume":"316","author":"Huneke","year":"2022","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.nsa.2023.103922_bib60","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/7854_2016_57","article-title":"A decade of orexin\/hypocretin and addiction: where are we now?","volume":"33","author":"James","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.nsa.2023.103922_bib61","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1046\/j.1365-2826.2000.00572.x","article-title":"Effects of orexins on the hypothalamic-pituitary-adrenal system","volume":"12","author":"J\u00e1szber\u00e9nyi","year":"2000","journal-title":"J. Neuroendocrinol."},{"issue":"26","key":"10.1016\/j.nsa.2023.103922_bib62","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.1523\/JNEUROSCI.0408-06.2006","article-title":"Panic-prone state induced in rats with GABA dysfunction in the dorsomedial hypothalamus is mediated by NMDA receptors","volume":"26","author":"Johnson","year":"2006","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.nsa.2023.103922_bib63","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nm.2075","article-title":"A key role for orexin in panic anxiety","volume":"16","author":"Johnson","year":"2010","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.nsa.2023.103922_bib64","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.physbeh.2012.04.016","article-title":"Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network","volume":"107","author":"Johnson","year":"2012","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.nsa.2023.103922_bib65","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/B978-0-444-59489-1.00009-4","article-title":"Orexin, stress, and anxiety\/panic states","volume":"198","author":"Johnson","year":"2012","journal-title":"Prog. Brain Res."},{"issue":"9","key":"10.1016\/j.nsa.2023.103922_bib66","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/da.22403","article-title":"Orexin 1 and 2 receptor involvement in CO2-induced panic-assoiciated behaviour and autonomic responses","volume":"32","author":"Johnson","year":"2015","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.nsa.2023.103922_bib67","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.brainresbull.2022.05.006","article-title":"Sleep-wake and arousal dysfunctions in post-traumatic stress disorder: role of orexin systems","volume":"186","author":"Kaplan","year":"2022","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nsa.2023.103922_bib68","unstructured":"S. Karamihalev, SciDraw, \u2018Human Brain Sagittal Outline\u2019 image. https:\/\/scidraw.io\/drawing\/395 Accessed 26 June 2023."},{"issue":"1","key":"10.1016\/j.nsa.2023.103922_bib69","first-page":"219","article-title":"Orexin A but not orexin B rapidly enters brain from blood by simple diffusion","volume":"289","author":"Kastin","year":"1999","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.nsa.2023.103922_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110166","article-title":"Multiple-dose clinical pharmacology of the selective orexin-1 receptor antagonist ACT-539313","volume":"108","author":"Kaufmann","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.nsa.2023.103922_bib71","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41386-021-01109-z","article-title":"The prefrontal cortex, pathological anxiety, and anxiety disorders","volume":"47","author":"Kenwood","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.nsa.2023.103922_bib72","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the national comorbidity survey","volume":"51","author":"Kessler","year":"1994","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.nsa.2023.103922_bib73","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.neubiorev.2020.07.040","article-title":"Dysregulation of the orexinergic system: a potential neuropeptide target in depression","volume":"118","author":"Khairuddin","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nsa.2023.103922_bib74","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbr.2016.12.007","article-title":"Increased anxiety but normal fear and safety learning in orexin-deficient mice","volume":"320","author":"Khalil","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.nsa.2023.103922_bib75","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5607\/en.2016.25.6.307","article-title":"Functional connectivity of basolateral amygdala neurons carrying orexin receptors and melanin-concentrating hormone receptors in regulating sociability and mood-related behaviors","volume":"25","author":"Kim","year":"2016","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.nsa.2023.103922_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2021.627633","article-title":"The paraventricular nucleus of the thalamus as an integrating and relay node in the brain anxiety network","volume":"15","author":"Kirouac","year":"2021","journal-title":"Front. Behav. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.nsa.2023.103922_bib77","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000119004","article-title":"The \u2019Trier Social Stress Test\u2019--a tool for investigating psychobiological stress responses in a laboratory setting","volume":"28","author":"Kirschbaum","year":"1993","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.nsa.2023.103922_bib78","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/bph.12324","article-title":"Orexin\/hypocretin receptor signalling cascades","volume":"171","author":"Kukkonen","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nsa.2023.103922_bib79","unstructured":"Kumar, SciDraw, DNA \u2018image\u2019. https:\/\/scidraw.io\/drawing\/383 Accessed 26 June 2023."},{"key":"10.1016\/j.nsa.2023.103922_bib80","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1097\/00001756-200006260-00034","article-title":"Centrally administered orexin\/hypocretin activates HPA axis in rats","volume":"11","author":"Kuru","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.nsa.2023.103922_bib81","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.autneu.2010.08.004","article-title":"Orexin links emotional stress to autonomic functions","volume":"161","author":"Kuwaki","year":"2011","journal-title":"Auton. Neurosci."},{"issue":"2","key":"10.1016\/j.nsa.2023.103922_bib82","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00213-010-1948-y","article-title":"Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats","volume":"212","author":"Li","year":"2010","journal-title":"Psychopharmacology (Berl.)"},{"issue":"5","key":"10.1016\/j.nsa.2023.103922_bib83","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.physbeh.2012.05.019","article-title":"Orexin-A induces anxiety-like behavior through interactions with glutamatergic receptors in the bed nucleus of the stria terminalis of rats","volume":"107","author":"Lungwitz","year":"2012","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.nsa.2023.103922_bib84","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbr.2018.12.037","article-title":"Orexin-A promotes EEG changes but fails to induce anxiety in rats","volume":"361","author":"Magdaleno-Madrigal","year":"2019","journal-title":"Behav. Brain Res."},{"issue":"10","key":"10.1016\/j.nsa.2023.103922_bib85","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nn.3810","article-title":"Motivational activation: a unifying hypothesis of orexin\/hypocretin function","volume":"17","author":"Mahler","year":"2014","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.nsa.2023.103922_bib86","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41583-018-0097-x","article-title":"The neurobiological basis of narcolepsy","volume":"20","author":"Mahoney","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.nsa.2023.103922_bib87","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/cne.1190","article-title":"Differential expression of orexin receptors 1 and 2 in the rat brain","volume":"435","author":"Marcus","year":"2001","journal-title":"J. Comp. Neurol."},{"issue":"5","key":"10.1016\/j.nsa.2023.103922_bib88","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s40265-022-01699-y","article-title":"Daridorexant: first approval","volume":"82","author":"Markham","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.nsa.2023.103922_bib89","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.neuropharm.2009.08.009","article-title":"Monoaminergic neuronal changes in orexin deficient mice","volume":"58","author":"Mori","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nsa.2023.103922_bib90","doi-asserted-by":"crossref","DOI":"10.1177\/2398212820930321","article-title":"The role of the locus coeruleus in the generation of pathological anxiety","volume":"4","author":"Morris","year":"2020","journal-title":"Brain Neurosci. Adv"},{"key":"10.1016\/j.nsa.2023.103922_bib91","first-page":"16","article-title":"Narcolepsy and psychiatric disorders: comorbidities or shared pathophysiology?","volume":"6","author":"Morse","year":"2018","journal-title":"Med. Sci."},{"key":"10.1016\/j.nsa.2023.103922_bib92","first-page":"30","article-title":"Neuroendocrine, autonomic, and metabolic responses to an orexin antagonist, suvorexant, in psychiatric patients with insomnia","volume":"14","author":"Nakamura","year":"2017","journal-title":"Innov. Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.nsa.2023.103922_bib93","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40263-013-0064-z","article-title":"Role of orexin in the pathophysiology of depression: potential for pharmacological intervention","volume":"27","author":"Nollet","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.nsa.2023.103922_bib94","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.sleep.2013.03.002","article-title":"Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population","volume":"14","author":"Ohayon","year":"2013","journal-title":"Sleep Med."},{"key":"10.1016\/j.nsa.2023.103922_bib95","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.peptides.2014.05.003","article-title":"Orexin A-induced anxiety-like behavior is mediated through GABA-ergic, \u03b1- and \u03b2-adrenergic neurotransmissions in mice","volume":"57","author":"Palotai","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.nsa.2023.103922_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2020.102019","article-title":"Involvement of orexin-A in the regulation of neuronal activity and emotional behaviors in central amygdala in rats","volume":"80","author":"Pan","year":"2020","journal-title":"Neuropeptides"},{"key":"10.1016\/j.nsa.2023.103922_bib97","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1177\/0269881113490328","article-title":"Functional topography of serotonergic systems supports the Deakin\/Graeff hypothesis of anxiety and affective disorders","volume":"27","author":"Paul","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.nsa.2023.103922_bib98","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0140-6736(21)00359-7","article-title":"Anxiety disorders","volume":"397","author":"Penninx","year":"2021","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.nsa.2023.103922_bib99","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nsa.2023.103922_bib100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.nsa.2023.103922_bib101","first-page":"1353","article-title":"The translational neural circuitry of anxiety","volume":"90","author":"Robinson","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nsa.2023.103922_bib102","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bbr.2012.12.064","article-title":"Orexin-1 receptor antagonism fails to reduce anxiety-like behaviour in either plus-maze-na\u00efve or plus-maze-experienced mice","volume":"243","author":"Rodgers","year":"2013","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.nsa.2023.103922_bib103","doi-asserted-by":"crossref","first-page":"191","DOI":"10.31887\/DCNS.2015.17.2\/proybyrne","article-title":"Treatment-refractory anxiety; definition, risk factors, and treatment challenges","volume":"17","author":"Roy-Byrne","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.nsa.2023.103922_bib104","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4088\/JCP.15m10262","article-title":"High rates of psychiatric comorbidity in narcolepsy: findings from the burden of narcolepsy disease (BOND) study of 9,312 patients in the United States","volume":"78","author":"Ruoff","year":"2017","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.nsa.2023.103922_bib105","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.nsa.2023.103922_bib106","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000514955","article-title":"Interaction between orexin neurons and monoaminergic systems","volume":"45","author":"Sakurai","year":"2021","journal-title":"Front. Neurol. Neurosci."},{"key":"10.1016\/j.nsa.2023.103922_bib107","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuron.2005.03.010","article-title":"Input of orexin\/hypocretin neurons revealed by a genetically encoded tracer in mice","volume":"46","author":"Sakurai T","year":"2005","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.nsa.2023.103922_bib108","first-page":"308","article-title":"Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humans, Transl","volume":"10","author":"Salvadore","year":"2020","journal-title":"Psychiatry"},{"issue":"4","key":"10.1016\/j.nsa.2023.103922_bib109","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s40265-020-01276-1","article-title":"Lemborexant: first approval","volume":"80","author":"Scott","year":"2020","journal-title":"Drugs"},{"issue":"50","key":"10.1016\/j.nsa.2023.103922_bib110","doi-asserted-by":"crossref","first-page":"20260","DOI":"10.1073\/pnas.1320325110","article-title":"Orexin\/hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus","volume":"110","author":"Sears","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.nsa.2023.103922_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109418","article-title":"Alleviating anxiety and taming trauma: novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder","volume":"226","author":"Singewald","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nsa.2023.103922_bib112","doi-asserted-by":"crossref","first-page":"383","DOI":"10.31887\/DCNS.2006.8.4\/ssmith","article-title":"The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress","volume":"8","author":"Smith","year":"2006","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.nsa.2023.103922_bib113","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuroscience.2021.06.006","article-title":"Orexin 1 and 2 receptors in the prelimbic cortex modulate threat valuation","volume":"468","author":"Soares","year":"2021","journal-title":"Neuroscience"},{"issue":"36","key":"10.1016\/j.nsa.2023.103922_bib114","doi-asserted-by":"crossref","first-page":"14549","DOI":"10.1523\/JNEUROSCI.1130-13.2013","article-title":"Orexin receptor-1 in the locus coeruleus plays an important role in cue-dependent fear memory consolidation","volume":"33","author":"Soya","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nsa.2023.103922_bib115","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1124\/pr.58.1.4","article-title":"Orexins in the regulation of the hypothalamic-pituitary-adrenal axis","volume":"58","author":"Spinazzi","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.nsa.2023.103922_bib116","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.yhbeh.2013.12.014","article-title":"The orexin-1 receptor antagonist SB-334867 attenuates anxiety in rats exposed to cat odor but not the elevated plus maze: an investigation of Trial 1 and Trial 2 effects","volume":"65","author":"Staples","year":"2014","journal-title":"Horm. Behav."},{"key":"10.1016\/j.nsa.2023.103922_bib117","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuropharm.2018.09.016","article-title":"Orexin 2 receptor stimulation enhances resilience, while orexin 2 inhibition promotes susceptibility, to social stress, anxiety and depression","volume":"143","author":"Staton","year":"2018","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.nsa.2023.103922_bib118","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-012-2736-7","article-title":"The brain orexin system and almorexant in fear-conditioned startle reactions in the rat","volume":"223","author":"Steiner","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"issue":"7","key":"10.1016\/j.nsa.2023.103922_bib119","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.psyneuen.2010.01.001","article-title":"Low cerebrospinal fluid and plasma orexin-A (hypocretin-1) concentrations in combat-related posttraumatic stress disorder","volume":"35","author":"Strawn","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.nsa.2023.103922_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2018.12.036","article-title":"Orexin\/hypocretin receptor modulation of anxiolytic and antidepressive responses during social stress and decision-making: potential for therapy","volume":"1731","author":"Summers","year":"2020","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.nsa.2023.103922_bib121","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2005.03.002","article-title":"Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior","volume":"1044","author":"Suzuki","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.nsa.2023.103922_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2023.101066","article-title":"Targeting the orexin\/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: from animal to clinical studies","volume":"69","author":"Ten-Blanco","year":"2023","journal-title":"Front. Neuroendocrinol."},{"issue":"6","key":"10.1016\/j.nsa.2023.103922_bib123","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrn3945","article-title":"Neuronal circuits for fear and anxiety","volume":"16","author":"Tovote","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nsa.2023.103922_bib124","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fnbeh.2013.00028","article-title":"Role of orexin in modulating arousal, feeding, and motivation","volume":"7","author":"Tsujino","year":"2013","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.nsa.2023.103922_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070012","article-title":"Chronic alterations in monoaminergic cells in the locus coeruleus in orexin neuron-ablated narcoleptic mice","volume":"8","author":"Tsujino","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nsa.2023.103922_bib126","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.bbr.2014.10.028","article-title":"The orexin-1 receptor antagonist SB-334867 decreases anxiety-like behavior and c-Fos expression in the hypothalamus of rats exposed to cat odor","volume":"278","author":"Vanderhaven","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"8","key":"10.1016\/j.nsa.2023.103922_bib127","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00213-014-3769-x","article-title":"Orexin neuropeptides contribute to the development and persistence of generalized avoidance behavior in the rat","volume":"232","author":"Viviani","year":"2015","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.nsa.2023.103922_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2021.100298","article-title":"Lateral hypothalamus orexinergic inputs to lateral habenula modulate maladaptation after social defeat stress","volume":"14","author":"Wang","year":"2021","journal-title":"Neurobiol. Stress"},{"issue":"2","key":"10.1016\/j.nsa.2023.103922_bib129","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/bph.12261","article-title":"Discovery and development of orexin receptor antagonists as therapeutics for insomnia","volume":"171","author":"Winrow","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nsa.2023.103922_bib130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1385\/MN:32:3:285","article-title":"Stress and arousal: the corticotrophin-releasing factor\/hypocretin circuitry","volume":"32","author":"Winsky-Sommerer","year":"2005","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nsa.2023.103922_bib131","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.neubiorev.2021.03.029","article-title":"Lateral septum as a nexus for mood, motivation, and movement","volume":"126","author":"Wirtshafter","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"4","key":"10.1016\/j.nsa.2023.103922_bib132","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.euroneuro.2005.04.012","article-title":"Size and burden of mental disorders in Europe\u2014a critical review and appraisal of 27 studies","volume":"15","author":"Wittchen","year":"2005","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.nsa.2023.103922_bib133","series-title":"ICD-11: International Classification of Diseases","year":"2022"},{"key":"10.1016\/j.nsa.2023.103922_bib134","doi-asserted-by":"crossref","first-page":"53","DOI":"10.26599\/SAB.2022.9060019","article-title":"Role of the hypothalamic paraventricular nucleus in anxiety disorders","volume":"2","author":"Wu","year":"2022","journal-title":"Stress Brain"},{"key":"10.1016\/j.nsa.2023.103922_bib135","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.neuroscience.2006.01.032","article-title":"Neuronal mechanisms of active (rapid eye movement) sleep induced by microinjections of hypocretin into the nucleus pontis oralis of the cat","volume":"140","author":"Xi","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.nsa.2023.103922_bib136","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0006-8993(01)02317-4","article-title":"Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat","volume":"901","author":"Xi","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.nsa.2023.103922_bib137","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1152\/jn.2002.87.6.2880","article-title":"Induction of active (REM) sleep and motor inhibition by hypocretin in the nucleus pontis oralis of the cat","volume":"87","author":"Xi","year":"2002","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nsa.2023.103922_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2021.101573","article-title":"The efficacy and safety of dual orexin receptor antagonists in primary insomnia: a systematic review and network meta-analysis","volume":"61","author":"Xue","year":"2022","journal-title":"Sleep Med. Rev."},{"issue":"9","key":"10.1016\/j.nsa.2023.103922_bib139","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.biopsych.2021.12.019","article-title":"Orexin 1 receptor antagonism in the basolateral amygdala shifts the balance from pro- to antistress signaling and behavior","volume":"91","author":"Yaeger","year":"2022","journal-title":"Biol. Psychiatr."},{"issue":"15","key":"10.1016\/j.nsa.2023.103922_bib140","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s40265-014-0294-5","article-title":"Suvorexant: first global approval","volume":"74","author":"Yang","year":"2014","journal-title":"Drugs"}],"container-title":["Neuroscience Applied"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772408523029046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772408523029046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T12:15:30Z","timestamp":1731500130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772408523029046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":140,"alternative-id":["S2772408523029046"],"URL":"https:\/\/doi.org\/10.1016\/j.nsa.2023.103922","relation":{},"ISSN":["2772-4085"],"issn-type":[{"value":"2772-4085","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of the orexin system in the neurobiology of anxiety disorders: Potential for a novel treatment target","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Applied","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nsa.2023.103922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European College of Neuropsychopharmacology.","name":"copyright","label":"Copyright"}],"article-number":"103922"}}